Learn More
Medchemexpress LLC Liraglutide TFA | 99.6% | 3751.20 | 5 MG

Supplier: Medchemexpress LLC HYP0014B5MG
Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1). It can activate GLP-1, resulting in the release of insulin when glucose concentration is elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner and can be utilized in research concerning type 2 diabetes.
- Agonist of glucagon-like peptide 1 receptor (GLP-1)
- Activates GLP-1, which leads to insulin release in the presence of increased glucose concentration
- Reduces glucagon secretion in a glucose-dependent manner
- Can be studied in research on type 2 diabetes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.